Severe hepatic side effects of ezetimibe.
Ezetimibe was introduced recently as a new class of cholesterol-lowering drugs. Until now only limited increases of transaminase levels were reported. We studied 2 patients with severe hepatic side effects of ezetimibe in a general community hospital. Ezetimibe may lead to 2 distinct types of severe hepatic side effects. Ezetimibe may rarely cause hepatotoxicity, severe cholestatic hepatitis, or acute autoimmune hepatitis.